Follow this innovation
[ via 
] [?]
Innovation
Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
Temple University
posted on 08/05/2011
The compounds of the present invention are in the form of peptides which possess anti-angiogenic activity. In all embodiments, the peptide may optionally comprise an amino-terminal and/or carboxy-terminal protecting group.
Advantages
Compounds can be used to treat cancer, rheumatoid arthritis, and certain ocular disorders characterized by undesired vascularization of the retina.
Innovation Details
File Number: 358KM
IP Protection
| Patent Number(s): | 6767889 |
|---|
License Online
This innovation currently is not available for online licensing. Please contact Stephen Nappi at Temple University for more information.
request more info
ProfileFind more innovations
